Biotechgate welcomes three new partners in Norway to further complete the Nordic Life Science Database

logos

Switzerland /Norway, November 2014 – Biotechgate welcomes the three Norwegian partners Innovation Norway, Oslo Cancer Cluster and Nansen Neuroscience Network. This partnership further completes the Nordic Life Sciences Database which allows users to search for companies in the Biotech, Pharma and Medtech area.

More than 170 Norwegian companies can currently be found in the Nordic Life Sciences Database (www.nordic-lifesciences.com). All profiles are updated continuously and the database will be further completed with new profiles over the next months. Due to the partnerships with Innovation Norway, Oslo Cancer Cluster and Nansen Neuroscience Network, the database can be used free of charge. It is also possible for companies to publish their profile at no cost.

Thanks to additional partners from Sweden and Denmark, also Swedish and Danish profiles can be found and viewed for free on the Nordic Life Sciences Database. The portal is part of Biotechgate, a global life science directory which provides information such as product pipelines, management contact details, financing information and much more of more than 30,000 companies in the Biotech, Pharma and Medtech space. Thanks to various search features the information is easily accessible.

“Being the primary government agency for industry development, it is a priority for Innovation Norway to promote our prosperous life science community. Norway has close to 200 companies depending on biotechnology in their daily business and a total of more than 400 companies when looking at life sciences at large. We are very pleased to enter into this collaboration with Biotechgate together with our most prominent biomedical clusters in oncology and neuroscience, respectively.”
Ole Jørgen Marvik, Sector Head, Health and Life Sciences, Innovation Norway

“Oslo Cancer Cluster is very pleased to have teamed up with Venture Valuation to profile our members through Biotechgate. We are reassured that this gives our SME-members a great exposure to the international VC and pharma milieu, which is important in our work to build a Norwegian Healthcare Industry.”
Ketil Widerberg, General Manager, Oslo Cancer Cluster

“Our companies work to address important and complex challenges. Success will require collaborations and partnerships, and we believe that Biotechgate can be a powerful tool to help build those. We look forward to offering this to our members.”
Leif Rune Skymoen, CEO of Nansen Neuroscience Network

“We are more than happy to close this gap in the Nordic Life Science Database. We are sure that having the Norwegian company profiles available on the database, will be a great contribution to all kind of actors active in the life sciences field – inside and outside of Norway and Scandinavia.”
Jost Renggli, COO, Venture Valuation / Biotechgate

 

For further information, please contact:

Jost Renggli, COO Biotechgate / Venture Valuation, Switzerland

+41 (43) 321 86 60, support@biotechgate.com

Click here to download the press release : Biotechgate welcomes three new partners in Norway to further complete the Nordic Life Science Database, Switzerland /Norway, November 2014, 2 pages, 70kb

Leave a Reply

Your email address will not be published. Required fields are marked *